Giampaolo Filice

Effective Assessment of egfr Mutation Status in Bronchoalveolar Lavage and Pleural Fluids by Next-Generation Sequencing

A. Marchetti, F. Buttitta, S. Rosini, 2012, Clinical Cancer Research.

Complex Mutations & Subpopulations of Deletions at Exon 19 of EGFR in NSCLC Revealed by Next Generation Sequencing: Potential Clinical Implications

A. Marchetti, F. Buttitta, F. Mucilli, 2012, PloS one.

ROS1 Gene Fusion in Advanced Lung Cancer in Women: A Systematic Analysis, Review of the Literature, and Diagnostic Algorithm.

A. Marchetti, F. Buttitta, F. Mucilli, 2017, JCO precision oncology.

Validation of a new algorithm for a quick and easy RT-PCR-based ALK test in a large series of lung adenocarcinomas: Comparison with FISH, immunohistochemistry and next generation sequencing assays.

A. Marchetti, F. Buttitta, F. Mucilli, 2016, Lung cancer.

Early Prediction of Response to Tyrosine Kinase Inhibitors by Quantification of EGFR Mutations in Plasma of NSCLC Patients

A. Marchetti, F. Buttitta, A. Chella, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Assessment of EGFR Mutations in Circulating Tumor Cell Preparations from NSCLC Patients by Next Generation Sequencing: Toward a Real-Time Liquid Biopsy for Treatment

A. Marchetti, F. Buttitta, A. Chella, 2014, PloS one.

ALK Protein Analysis by IHC Staining after Recent Regulatory Changes: A Comparison of Two Widely Used Approaches, Revision of the Literature, and a New Testing Algorithm

A. Marchetti, F. Buttitta, F. Mucilli, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Imaging , Diagnosis , Prognosis Effective Assessment of egfr Mutation Status in Bronchoalveolar Lavage and Pleural Fluids by Next-Generation Sequencing

A. Marchetti, F. Buttitta, S. Rosini, 2013 .